IncTank Ventures has put up $1 million in funding to back Cambridge, MA-based start-up Ligon Discovery. Ligon is hoping that its technology platform, Small-Molecule Microarrays (SMMs), will bring the power of microarrays to target screening. The technology was developed at Havard University and the Broad Institute, and allows for massively-parallel screening against protein targets of any function. Mass High Tech notes that the company was founded by Broad Institute and Havard members Patrick Kleyn, Angela Koehler and Benjamin Ebert, among others.
- here's the Mass High Tech brief